266 related articles for article (PubMed ID: 36328513)
1. A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database.
Musa HH; Musa TH
Hum Vaccin Immunother; 2022 Nov; 18(6):2135927. PubMed ID: 36328513
[TBL] [Abstract][Full Text] [Related]
2. The top 100 most cited articles on COVID-19 vaccine: a bibliometric analysis.
Wang W; Wang H; Yao T; Li Y; Yi L; Gao Y; Lian J; Feng Y; Wang S
Clin Exp Med; 2023 Oct; 23(6):2287-2299. PubMed ID: 36939968
[TBL] [Abstract][Full Text] [Related]
3. Bibliometric Analysis of Global Scientific Production on COVID-19 and Vaccines.
Sousa Neto AR; Carvalho ARB; Ferreira da Silva MD; Rêgo Neta MM; Sena IVO; Almeida RN; Filha FSSC; Lima E Silva LL; Costa GRD; Lira IMDS; Portela DMMC; Oliveira E Silva AT; Rabêlo CBM; Valle ARMDC; Moura MEB; Freitas DRJ
Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981704
[TBL] [Abstract][Full Text] [Related]
4. Global research on RNA vaccines for COVID-19 from 2019 to 2023: a bibliometric analysis.
Chen Z; Liu Z; Feng Y; Shi A; Wu L; Sang Y; Li C
Front Immunol; 2024; 15():1259788. PubMed ID: 38426106
[TBL] [Abstract][Full Text] [Related]
5. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer.
Chen Y; Cheng L; Lian R; Song Z; Tian J
Biosci Trends; 2021 May; 15(2):64-73. PubMed ID: 33746182
[TBL] [Abstract][Full Text] [Related]
7. Current status of coronavirus disease 2019 vaccine research based on bibliometric analysis.
Gan P; Pan X; Huang S; Xia H; Zhou X; Tang X
Hum Vaccin Immunother; 2022 Nov; 18(6):2119766. PubMed ID: 36494998
[TBL] [Abstract][Full Text] [Related]
8. Tracking the progress in COVID-19 and vaccine safety research - a comprehensive bibliometric analysis of publications indexed in Scopus database.
Akintunde TY; Chen S; Musa TH; Amoo FO; Adedeji A; Ibrahim E; Tassang AE; Musa IH; Musa HH
Hum Vaccin Immunother; 2021 Nov; 17(11):3887-3897. PubMed ID: 34613876
[TBL] [Abstract][Full Text] [Related]
9. Decoding trends in mRNA vaccine research: A comprehensive bibliometric study.
Zhang C; Wang Y; Peng J; Wen X; Zhang Y; Li K; Du H; Hu X
Hum Vaccin Immunother; 2024 Dec; 20(1):2355037. PubMed ID: 38813652
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
11. Research trends in COVID-19 vaccine: a bibliometric analysis.
Ahmad T; Murad MA; Baig M; Hui J
Hum Vaccin Immunother; 2021 Aug; 17(8):2367-2372. PubMed ID: 33687303
[No Abstract] [Full Text] [Related]
12. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
13. The vaccine journey for COVID-19: a comprehensive systematic review of current clinical trials in humans.
Checcucci E; Piramide F; Pecoraro A; Amparore D; Campi R; Fiori C; Elhage O; Kotecha P; Vyakarnam A; Serni S; Dasgupta P; Porpiglia F
Panminerva Med; 2022 Mar; 64(1):72-79. PubMed ID: 32456404
[TBL] [Abstract][Full Text] [Related]
14. A bibliometric analysis using VOSviewer of publications on COVID-19.
Yu Y; Li Y; Zhang Z; Gu Z; Zhong H; Zha Q; Yang L; Zhu C; Chen E
Ann Transl Med; 2020 Jul; 8(13):816. PubMed ID: 32793661
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
Sharif N; Alzahrani KJ; Ahmed SN; Dey SK
Front Immunol; 2021; 12():714170. PubMed ID: 34707602
[TBL] [Abstract][Full Text] [Related]
16. Bibliometric Analysis and Visualization Mapping of Anthrax Vaccine Publications from 1991 through 2021.
Ahmad T; Baig M; Othman SS; Malibary H; Ahmad S; Rasheed SM; Al Bataineh MT; Al-Omari B
Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891169
[TBL] [Abstract][Full Text] [Related]
17. Tracking trends in COVID-19 vaccines based on 47 different vaccines: A bibliometric review.
Tao Z; Xu C; Cheng L; Zhang M; Xu J; Zheng Q; Zhang J; Lu W; Sheng C; Tian J
Hum Vaccin Immunother; 2023 Aug; 19(2):2242747. PubMed ID: 37585593
[TBL] [Abstract][Full Text] [Related]
18. The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines.
Rosen B; Davidovitch N; Chodick G; Israeli A
Isr J Health Policy Res; 2022 Nov; 11(1):39. PubMed ID: 36419188
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine Candidates.
Wu Y; Zhang H; Meng L; Li F; Yu C
Front Immunol; 2022; 13():906457. PubMed ID: 35663946
[TBL] [Abstract][Full Text] [Related]
20. Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis.
Ciampi E; Uribe-San-Martin R; Soler B; García L; Guzman J; Pelayo C; Jürgensen L; Guzman I; Vera F; Galleguillos L; Cárcamo C
Mult Scler Relat Disord; 2022 Mar; 59():103690. PubMed ID: 35182880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
